Randomized Trial of a Decision Aid for BRCA1/BRCA2 Mutation Carriers: Impact on Measures of Decision Making and Satisfaction

Health Psychology

Volumn 28, Issue 1, 2009, Pages 11-19

  Schwartz, Marc D ^a   Valdimarsdottir, Heiddis B ^b   DeMarco, Tiffani A ^a   Peshkin, Beth N ^a   Lawrence, William ^a   Rispoli, Jessica ^b   Brown, Karen ^b   Isaacs, Claudine ^a   O'Neill, Suzanne ^c   Shelby, Rebecca ^d   Grumet, Sherry C ^e   McGovern, Margaret M ^b   Garnett, Sarah ^a   Bremer, Heather ^a   Leaman, Suzanne ^a   O'Mara, Kathryn ^a   Kelleher, Sarah ^a   Komaridis, Kathryn ^a  

^a Fisher Center   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Englewood Hospital   (United States)

Author keywords

BRCA1; BRCA2; decision aid; risk reducing mastectomy

Indexed keywords

ADULT; AGED; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HUMANS; MASTECTOMY; MIDDLE AGED; PATIENT SATISFACTION; RISK ASSESSMENT;

EID: 58849100511     PISSN: 02786133     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0013147     Document Type: Article

References (36)

1. Botkin J.R., Smith K.S., Croyle R.T., Baty B.J., Wylie J.E., Dutson D., et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing. American Journal of Medical Genetics 118A (2003) 201-209
2. Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. Journal of the National Cancer Institute 91 (1999) 1310-1316
3. Chen S., and Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology 25 (2007) 1329-1333
4. Edwards W., and Newman J. Multiattribute evaluation, vol. 26. Quantitative Applications in the Social Sciences Series (1982), Sage, Thousand Oaks, CA
5. Gattellari M., and Ward J.E. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Education and Counseling 57 (2005) 168-182
6. Goel V., Sawka C.A., Thiel E.C., Gort E.H., and O'Connor A.M. Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Medical Decision Making 21 (2001) 1-6
7. Green M.J., Peterson S.K., Baker M.W., Harper G.R., Friedman L.C., Rubinstein W.S., et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: A randomized controlled trial. Journal of the American Medical Association 292 (2004) 442-452
8. Herrinton L.J., Barlow W.E., Yu O., Geiger A.M., Elmore J.G., Barton M.B., et al. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A cancer research network project. Journal of Clinical Oncology 23 (2005) 4275-4286
9. Holmes-Rovner M., Kroll J., Schmitt N., Rovner D.R., Breer M.L., Rothert M.L., et al. Patient satisfaction with health care decisions: The satisfaction with decision scale. Medical Decision Making 16 (1996) 58-64
10. Kauff N.D., Satagopan J.M., Robson M.E., Scheuer L., Hensley M., Hudis C.A., et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine 346 (2002) 1609-1615
11. Kaufman E.M., Peshkin B.N., Lawrence W.F., Shelby R., Isaacs C., Brown K., et al. Development of an interactive decision aid for female BRCA1/BRCA2 carriers. Journal of Genetic Counseling 12 (2003) 109-129
12. Keeney R.L., and Raiffa H. Decisions with multiple objectives: Preferences and value tradeoffs (1993), Cambridge University Press, Cambridge, MA
13. McDonnell S.K., Schaid D.J., Myers J.L., Grant C.S., Donohue J.H., Woods J.E., et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. Journal of Clinical Oncology 19 (2001) 3938-3943
14. Metcalfe K., Lynch H.T., Ghadirian P., Tung N., Olivotto I., Warner E., et al. Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology 22 (2004) 2328-2335
15. Metcalfe K.A., Poll A., O'Connor A., Gershman S., Armel S., Finch A., et al. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics 72 (2007) 208-217
16. Molenaar S., Sprangers M.A., Rutgers E.J., Luiten E.J., Mulder J., Bossuyt P.M., et al. Decision support for patients with early-stage breast cancer: Effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. Journal of Clinical Oncology 19 (2001) 1676-1687
17. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Genetic/familial high-risk assessment: Breast and ovarian. Version 1.2006 (2006). http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.p df Retrieved July 17, 2006 from http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.p df
18. O'Connor A.M., Fiset V., DeGrasse C., Graham I.D., Evans W., Stacey D., et al. Decision aids for patients considering options affecting cancer outcomes: Evidence of efficacy and policy implications. Journal of the National Cancer Institute Monographs (1999) 67-80
19. O'Connor A.M. Validation of a decisional conflict scale. Medical Decision Making 15 (1995) 25-30
20. O'Connor A.M., Stacey D., Entwistle V., Llewellyn-Thomas H., Rovner D., Holmes-Rovner M., et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews (Online) (2003) CD001431
21. O'Connor A.M., Jacobsen M.J., and Stacey D. An evidence-based approach to managing women's decisional conflict. Journal of Obstetric, Gynecologic, and Neonatal Nursing 31 (2002) 570-581
22. O'Connor A.M., Tugwell P., Wells G.A., Elmslie T., Jolly E., Hollingworth G., et al. A decision aid for women considering hormone therapy after menopause: Decision support framework and evaluation. Patient Education and Counseling 33 (1998) 267-279
23. Peralta E.A., Ellenhorn J.D., Wagman L.D., Dagis A., Andersen J.S., and Chu D.Z. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. American Journal of Surgery 180 (2000) 439-445
24. Peshkin B.N., Schwartz M.D., Isaacs C., Hughes C., Main D., and Lerman C. Utilization of mammography in a clinically-based sample of women following BRCA1/2 testing. Cancer Epidemiology, Biomarkers and Prevention 11 (2002) 1115-1118
25. Rebbeck T.R., Lynch H.T., Neuhausen S.L., Narod S.A., Van't Veer L., Garber J.E., et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New England Journal of Medicine 346 (2002) 1616-1622
26. Schwartz M.D., Benkendorf J., Lerman C., Isaacs C., Ryan-Robertson A., and Johnson L. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: Testing among Ashkenazi Jewish women. Cancer 92 (2001) 932-940
27. Schwartz M.D., Peshkin B.N., Hughes C., Main D., Isaacs C., and Lerman C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. Journal of Clinical Oncology 20 (2002) 514-520
28. Schwartz M.D., Peshkin B.N., Tercyak K.P., Taylor K.L., and Valdimarsdottir H. Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychology 24 (2005) S78-S84
29. Smith K.L., and Robson M.E. Update on hereditary breast cancer. Current Oncology Reports 8 (2006) 14-21
30. Tilanus-Linthorst M., Verhoog L., Obdeijn I.M., Bartels K., Menke-Pluymers M., Eggermont A., et al. A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography. International Journal of Cancer 102 (2002) 91-95
31. van Roosmalen M.S., Stalmeier P.F., Verhoef L.C., Hoekstra-Weebers J.E., Oosterwijk J.C., Hoogerbrugge N., et al. Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology 22 (2004) 3293-3301
32. van Roosmalen M.S., Stalmeier P.F., Verhoef L.C., Hoekstra-Weebers J.E., Oosterwijk J.C., Hoogerbrugge N., et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. British Journal of Cancer 90 (2004) 333-342
33. Volk R.J., Spann S.J., Cass A.R., and Hawley S.T. Patient education for informed decision making about prostate cancer screening: A randomized controlled trial with 1-year follow-up. Annals of Family Medicine 1 (2003) 22-28
34. Wakefield C.E., Meiser B., Homewood J., Peate M., Taylor A., Lobb E., et al. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Research and Treatment (2007) Published Online ahead of print
35. Waljee J.F., Rogers M.A., and Alderman A.K. Decision aids and breast cancer: Do they influence choice for surgery and knowledge of treatment options?. Journal of Clinical Oncology 25 (2007) 1067-1073
36. Whelan T., Levine M., Willan A., Gafni A., Sanders K., Mirsky D., et al. Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: A randomized trial. Journal of the American Medical Association 292 (2004) 435-441